GLP Watchdog

altRX vs Polly

altRX has an open FDA warning letter dated June 8, 2026. Polly has none. On compounded tirzepatide injection, altRX costs $1,560 less a year at standing rates: $149 a month against $279 a month at Polly. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Polly

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Polly logo

Polly

8.4/10

FDA warning letters
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
Lowest standing price
$89/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked November 2026
Visit altRX
Visit Polly

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Polly pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Polly 8.4). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Polly has none.

  2. 02

    altRX names four pharmacies. Polly names two pharmacies, all 503A.

  3. 03

    On compounded tirzepatide injection, altRX costs $1,560 less a year at standing rates: $149 a month against $279 a month at Polly. It is one of two products the two sell at comparable terms.

  4. 04

    Only altRX lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    altRX states you can cancel at any time; Polly does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Polly

Compounded semaglutide injection

$89/moLower

$1,068 a year

$179/mo

$2,148 a year

Compounded tirzepatide injection

$149/moLower

$1,788 a year

$279/mo

$3,348 a year

Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Not stated
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
Month to month, or a 3- or 6-month supply charged at checkout
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
Full refund only before the medical intake is submitted; 3- and 6-month plans cannot be refunded once the first month has passed
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. altRX: September 28, 2026. Polly: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • $1,080 a year less on compounded semaglutide injection
  • $1,560 a year less on compounded tirzepatide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Polly does not price
  • States you can cancel at any time
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Polly

8.4/10
  • No FDA warning letter on record
Visit Polly

Scores

altRX 8.8 · Polly 8.4 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
5.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Polly: questions

altRX has an open FDA warning letter dated June 8, 2026. Polly has none. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Polly names two pharmacies, all 503A. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
altRX, by $1,080 a year at standing rates. altRX: $89 a month, about $1,068 a year. Polly: $179 a month, about $2,148 a year.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Polly does not state its cancellation terms.
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Polly pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Polly 8.4).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks